Great app
Simple yet very helpful especially for urologist.
Description
"Urology Partin Tables: Prostate Cancer Evaluation" is an app to help medical doctor or urologist to predict pathological stage of prostate cancer patients based on commonly available preoperative data (serum prostate-specific antigen (PSA) level, clinical stage, and biopsy Gleason score). For decades, urologists around the world have relied on the tables for counseling patients preoperatively and for surgical planning.
Why should you choose "Urology Partin Tables: Prostate Cancer Evaluation"?
- Based on the latest Partin Tables nomogram.
- Simple and very easy to use.
- Accurate and precise calculation.
- Prediction of the pathological stage of prostate cancer.
- It is totally free. Download now!
Around 93% of newly diagnosed prostate cancer patients present with localized or regional disease. The use of "Urology Partin Tables: Prostate Cancer Evaluation" app may shift toward identifying men with intermediate-risk to high-risk disease for whom the ratio of treatment benefit to harm may be greatest, or to identify men with low-risk to intermediate-risk disease who may benefit from active surveillance. The results were from an analysis of 5629 men treated with prostatectomy (without additional therapy) between 2006 and 2011 at the Johns Hopkins Hospital. In this app, you should input patient's information regarding clinical stage, serum PSA, and gleason score. "Urology Partin Tables: Prostate Cancer Evaluation" app will then calculate the probability of pathological stage (organ confined, extraprotastic extension, seminal vesicle involvement, and lymph node involvement).
Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "Urology Partin Tables: Prostate Cancer Evaluation" app might be different with your local practice. Consult to expert doctor whenever necessary.
Hide
Show More...
Why should you choose "Urology Partin Tables: Prostate Cancer Evaluation"?
- Based on the latest Partin Tables nomogram.
- Simple and very easy to use.
- Accurate and precise calculation.
- Prediction of the pathological stage of prostate cancer.
- It is totally free. Download now!
Around 93% of newly diagnosed prostate cancer patients present with localized or regional disease. The use of "Urology Partin Tables: Prostate Cancer Evaluation" app may shift toward identifying men with intermediate-risk to high-risk disease for whom the ratio of treatment benefit to harm may be greatest, or to identify men with low-risk to intermediate-risk disease who may benefit from active surveillance. The results were from an analysis of 5629 men treated with prostatectomy (without additional therapy) between 2006 and 2011 at the Johns Hopkins Hospital. In this app, you should input patient's information regarding clinical stage, serum PSA, and gleason score. "Urology Partin Tables: Prostate Cancer Evaluation" app will then calculate the probability of pathological stage (organ confined, extraprotastic extension, seminal vesicle involvement, and lymph node involvement).
Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "Urology Partin Tables: Prostate Cancer Evaluation" app might be different with your local practice. Consult to expert doctor whenever necessary.
Screenshots
Urology Partin Tables FAQ
-
Is Urology Partin Tables free?
Yes, Urology Partin Tables is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is Urology Partin Tables legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does Urology Partin Tables cost?
Urology Partin Tables is free.
-
What is Urology Partin Tables revenue?
To get estimated revenue of Urology Partin Tables app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Vietnam yet.
Ratings History
Urology Partin Tables Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Urology Partin Tables Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
MenHealth
|
Unlock
|
Unlock
|
0
|
|
5 months ago | |
N/A
N/A
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
Urology Research and Practice
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Cystomanometer
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
Gil Vernet’s Urology Drawings
SGV Collection Wall Paper
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Nyushko prostate nomograms
Risk of Progression of PCa
|
Unlock
|
Unlock
|
0
|
|
8 months ago | |
Prostate Cancer Manager
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Evidencio
Medical prediction models
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
UroRecord
Keep track of your IPSS/SHIM!
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
EAU-Guidelines
|
Unlock
|
Unlock
|
0
|
|
7 months ago |
Urology Partin Tables Installs
Last 30 days
Urology Partin Tables Revenue
Last 30 daysUrology Partin Tables Revenue and Downloads
Gain valuable insights into Urology Partin Tables performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Putu Angga Risky Raharja
- Languages
- English
- Recent release
- 3.1 (3 years ago )
- Released on
- Apr 27, 2017 (7 years ago )
- Also available in
- Indonesia, Russia, Pakistan, Italy, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Netherlands, Norway, New Zealand, Peru, Philippines, India, Poland, Portugal, Romania, Saudi Arabia, Sweden, Singapore, Slovenia, Thailand, Türkiye, Ukraine, United States, Vietnam, South Africa, Denmark, Argentina, Austria, Australia, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, United Arab Emirates, Dominican Republic, Algeria, Ecuador, Egypt, Spain, Finland, France, United Kingdom, Greece, Hong Kong SAR China, Hungary, Ireland, Israel
- Last Updated
- 1 week ago